| PG |
Report |
Organic sales growth |
BEAT |
pred ~2.4% vs. cons 2.1% |
MEDIUM |
| PG |
Report |
Core EPS |
BEAT |
pred ~$1.44 vs. cons $1.42 |
MEDIUM |
| PG |
Report |
Core operating margin |
MISS |
pred ~19.6% vs. cons 20.0% |
MEDIUM |
| PG |
Guide |
Fiscal 2027 organic sales growth guidance |
BETTER |
guide ~3.0% vs. cons 2.8% (fiscal 2027) |
MEDIUM |
| PG |
Guide |
Fiscal 2027 core EPS growth guidance |
LOWER |
guide ~2.0% vs. cons 4.3% (fiscal 2027) |
HIGH |
| PG |
Guide |
Fiscal 2027 commodity, tariff and restructuring cost headwind |
LOWER |
guide ~$1.1B pretax vs. cons ~$0.8B pretax (fiscal 2027) |
MEDIUM |
| PG |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.8% |
— |
MEDIUM |
| PG |
Return |
5-day cumulative residual |
-3.5% (FOLLOW-THROUGH) |
A modest quarterly organic-sales and EPS beat is likely outweighed by fiscal-2027 core-EPS guidance of ~2.0% versus ~4.3% consensus: the implied out-period margin and productivity math drives estimate cuts despite the beat. |
MEDIUM |